Saudi Arabia has become a leading pharmaceutical market across the Middle East. This is mainly due to rising healthcare needs and increasing government initiatives.
A key segment of the Saudi pharmaceutical drugs industry is generic drugs. According to Coherent Market Insights, the generic drugs segment is set to dominate the target industry during the forecast period. It accounted for around US$ 6 billion in 2023, representing 48.4%.
The market share of generic drugs in Saudi Arabia is expected to further increase through 2030. This is due to growing demand for affordable medicines in Saudi Arabia.
Growing Demand for Generic Drugs
The Saudi Arabia pharmaceutical drugs industry has been dominated by the branded drugs segment for a long time now. However, growing prevalence of chronic diseases like diabetes and cardiovascular disorders is creating a high demand for cost-effective medicine.
Generic drugs play a key role in improving the accessibility and affordability of medical treatment. They are generally sold at lower prices, making them an ideal solution to control healthcare expenditure.
Regulatory authorities like the Saudi Food and Drug Authority are constantly promoting the adoption of generic drugs. They are implementing strict quality regulations to ensure production and marketing of safe and effective medicines.
Key Benefits of Generic Drugs in Saudi Arabia
- Cost-effectiveness
One of the most attractive benefits of generic drugs is their cost-effectiveness. These drugs are priced lower than branded ones. This makes them more affordable for patients and reduces healthcare costs.
